The link between stress disorders and autonomic dysfunction in muscular dystrophy

Frontiers in Physiology

Volumn 5 JAN, Issue , 2014, Pages

  Sabharwal, Rasna ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Anxiety; Baroreceptor reflex; Depression; Heart rate variability; Neuromuscular disease; Parasympathetic nervous system; Sympathetic nervous system

Indexed keywords

EID: 84893436707     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00025     Document Type: Article

References (80)

1. Anastasi, G., Tomasello, F., Di Mauro, D., Cutroneo, G., Favaloro, A., Conti, A., et al. (2012). Expression of sarcoglycans in the human cerebral cortex: an immunohistochemical and molecular study. Cells Tissues Organs 196, 470-480. doi: 10.1159/000336842.
2. Anderson, J. L., Head, S. I., and Morley, J. W. (2004). Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice. Brain Res. 1019, 289-292. doi: 10.1016/j.brainres.2004.06.011.
3. Armando, I., Volpi, S., Aguilera, G., and Saavedra, J. M. (2007). Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res. 1142, 92-99. doi: 10.1016/j.brainres.2007.01.037.
4. Aronow, W. S., Ahn, C., Mercando, A. D., and Epstein, S. (1996). Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am. J. Cardiol. 78, 1175-1176.
5. Bader, M., Santos, R. A., Unger, T., and Steckelings, U. M. (2012). New therapeutic pathways in the RAS. J. Renin Angiotensin Aldosterone Syst. 13, 505-508. doi: 10.1177/1470320312466519.
6. Badoer, E. (2001). Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin. Exp. Pharmacol. Physiol. 28, 95-99. doi: 10.1046/j.1440-1681.2001.03413.x.
7. Baiardi, G., Bregonzio, C., Jezova, M., Armando, I., and Saavedra, J. M. (2004). Angiotensin II AT1 receptor blockade prolongs the lifespan of spontaneously hypertensive rats and reduces stress-induced release of catecholamines, glucocorticoids, and vasopressin. Ann. N.Y. Acad. Sci. 1018, 131-136. doi: 10.1196/annals.1296.015.
8. Barton, D. A., Dawood, T., Lambert, E. A., Esler, M. D., Haikerwal, D., Brenchley, C., et al. (2007). Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J. Hypertens. 25, 2117-2124. doi: 10.1097/HJH.0b013e32829baae7.
9. Bild, W., and Ciobica, A. (2013). Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala. J. Affect. Disord. 145, 165-171. doi: 10.1016/j.jad.2012.07.024.
10. Billard, C., Gillet, P., Signoret, J. L., Uicaut, E., Bertrand, P., Fardeau, M., et al. (1992). Cognitive functions in Duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy. Neuromuscul. Disord. 2, 371-378. doi: 10.1016/S0960-8966(06)80008-8.
11. Billman, G. E., Schwartz, P. J., and Stone, H. L. (1982). Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 66, 874-880. doi: 10.1161/01.CIR.66.4.874.
12. Blain, A., Greally, E., Laval, S., Blamire, A., Straub, V., and MacGowan, G. A. (2013). Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy. PLoS ONE 8:e57260. doi: 10.1371/journal.pone.0057260.
13. Bostwick, J. M. (2010). A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy. Mayo Clin. Proc. 85, 538-550. doi: 10.4065/mcp.2009.0565.
14. Bregonzio, C., Seltzer, A., Armando, I., Pavel, J., and Saavedra, J. M. (2008). Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats. Stress 11, 457-466. doi: 10.1080/10253890801892040.
15. Cabello-Verrugio, C., Morales, M. G., Cabrera, D., Vio, C. P., and Brandan, E. (2012). Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles. J. Cell. Mol. Med. 16, 752-764. doi: 10.1111/j.1582-4934.2011.01354.x.
16. Carney, R. M., Freedland, K. E., Stein, P. K., Watkins, L. L., Catellier, D., Jaffe, A. S., et al. (2003). Effects of depression on QT interval variability after myocardial infarction. Psychosom. Med. 65, 177-180. doi: 10.1097/01.PSY.0000033129.21715.4B.
17. Cechetto, D. F., and Chen, S. J. (1990). Subcortical sites mediating sympathetic responses from insular cortex in rats. Am. J. Physiol. 258, R245-R255.
18. Chaichana, K. L., Buffington, A. L., Brandes, M., Edwin, D., and Lee, H. B. (2007). Treatment of psychiatric comorbidities in a patient with becker muscular dystrophy. Psychosomatics 48, 167-169. doi: 10.1176/appi.psy.48.2.167.
19. Chapleau, M. W., Li, Z., Meyrelles, S. S., Ma, X., and Abboud, F. M. (2001). Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann. N.Y. Acad. Sci. 940, 1-19. doi: 10.1111/j.1749-6632.2001.tb03662.x.
20. Cheng, V. E., and Prior, D. L. (2013). Peripartum cardiomyopathy in a previously asymptomatic carrier of duchenne muscular dystrophy. Heart Lung Circ. 22, 677-681. doi: 10.1016/j.hlc.2012.11.015.
21. Chisari, C., Licitra, R., Pellegrini, M., Pellegrino, M., and Rossi, B. (2009). Fluoxetine blocks myotonic runs and reverts abnormal surface electromyogram pattern in patients with myotonic dystrophy type 1. Clin. Neuropharmacol. 32, 330-334. doi: 10.1097/WNF.0b013e3181ae5546.
22. Chrousos, G. P. (2009). Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5, 374-381. doi: 10.1038/nrendo.2009.106.
23. Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., et al. (2007). Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204-210. doi: 10.1038/nm1536.
24. Davies, J. E., Winokur, T. S., Aaron, M. F., Benza, R. L., Foley, B. A., and Holman, W. L. (2001). Cardiomyopathy in a carrier of Duchenne's muscular dystrophy. J. Heart Lung Transplant. 20, 781-784. doi: 10.1016/S1053-2498(00)00240-0.
25. Della Marca, G., Frusciante, R., Scatena, M., Dittoni, S., Testani, E., Vollono, C., et al. (2010). Heart rate variability in facioscapulohumeral muscular dystrophy. Funct. Neurol. 25, 211-216.
26. Delliaux, S., Brerro-Saby, C., Steinberg, J. G., and Jammes, Y. (2009). Reactive oxygen species activate the group IV muscle afferents in resting and exercising muscle in rats. Pflugers Arch. 459, 143-150. doi: 10.1007/s00424-009-0713-8.
27. DiBona, G. F., and Sawin, L. L. (1995). Increased renal nerve activity in cardiac failure: arterial vs. cardiac baroreflex impairment. Am. J. Physiol. 268, R112-R116.
28. Douniol, M., Jacquette, A., Guile, J. M., Tanguy, M. L., Angeard, N., Heron, D., et al. (2009). Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy. Eur. Child Adolesc. Psychiatry 18, 705-715. doi: 10.1007/s00787-009-0037-4.
29. Dubowitz, V., and Crome, L. (1969). The central nervous system in Duchenne muscular dystrophy. Brain 92, 805-808. doi: 10.1093/brain/92.4.805.
30. DuboYang, G., Xi, Z. X., Wan, Y., Wang, H., and Bi, G. (1993). Changes in circulating and tissue angiotensin II during acute and chronic stress. Biol. Signals 2, 166-172. doi: 10.1159/000109488.
31. Dubuc, D., Meune, C., Lerebours, G., Devaux, J. Y., Vaksmann, G., and Becane, H. M. (2005). Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J. Am. Coll. Cardiol. 45, 855-857. doi: 10.1016/j.jacc.2004.09.078.
32. Esler, M., Alvarenga, M., Lambert, G., Kaye, D., Hastings, J., Jennings, G., et al. (2004). Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Ann. N.Y. Acad. Sci. 1018, 505-514. doi: 10.1196/annals.1296.062.
33. Fitzpatrick, C., Barry, C., and Garvey, C. (1986). Psychiatric disorder among boys with Duchenne muscular dystrophy. Dev. Med. Child Neurol. 28, 589-595. doi: 10.1111/j.1469-8749.1986.tb03900.x.
34. Freedland, K. E., Rich, M. W., Skala, J. A., Carney, R. M., Davila-Roman, V. G., and Jaffe, A. S. (2003). Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom. Med. 65, 119-128. doi: 10.1097/01.PSY.0000038938.67401.85.
35. Glassman, A. H., O'Connor, C. M., Califf, R. M., Swedberg, K., Schwartz, P., Bigger, J. T., et al. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288, 701-709. doi: 10.1001/jama.288.6.701.
36. Grippo, A. J., Moffitt, J. A., and Johnson, A. K. (2002). Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1333-R1341.
37. Grippo, A. J., Moffitt, J. A., and Johnson, A. K. (2008). Evaluation of baroreceptor reflex function in the chronic mild stress rodent model of depression. Psychosom. Med. 70, 435-443. doi: 10.1097/PSY.0b013e31816ff7dd.
38. Groh, W. J. (2012). Arrhythmias in the muscular dystrophies. Heart Rhythm 9, 1890-1895. doi: 10.1016/j.hrthm.2012.06.038.
39. Guzzetti, S., La Rovere, M. T., Pinna, G. D., Maestri, R., Borroni, E., Porta, A., et al. (2005). Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure. Eur. Heart J. 26, 357-362. doi: 10.1093/eurheartj/ehi067.
40. Head, G. A., and Mayorov, D. N. (2001). Central angiotensin and baroreceptor control of circulation. Ann. N.Y. Acad. Sci. 940, 361-379. doi: 10.1111/j.1749-6632.2001.tb03691.x.
41. Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., and Kobilka, B. K. (1995). Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377, 744-747. doi: 10.1038/377744a0.
42. Hunt, J. L., Zaretsky, D. V., Sarkar, S., and Dimicco, J. A. (2010). Dorsomedial hypothalamus mediates autonomic, neuroendocrine, and locomotor responses evoked from the medial preoptic area. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R130-R140. doi: 10.1152/ajpregu.00574.2009.
43. Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., et al. (1995). Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377, 748-750. doi: 10.1038/377748a0.
44. Inoue, M., Mori, K., Hayabuchi, Y., Tatara, K., and Kagami, S. (2009). Autonomic function in patients with Duchenne muscular dystrophy. Pediatr. Int. 51, 33-40. doi: 10.1111/j.1442-200X.2008.02656.x.
45. Johnson, A. K., and Grippo, A. J. (2006). Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J. Physiol. Pharmacol. 57(Suppl. 11), 5-29.
46. Kaufman, M. P. (2012). The exercise pressor reflex in animals. Exp. Physiol. 97, 51-58. doi: 10.1113/expphysiol.2011.057539.
47. Lahmeyer, H. W., and Bellur, S. N. (1987). Cardiac regulation and depression. J. Psychiatr. Res. 21, 1-6. doi: 10.1016/0022-3956(87)90004-5.
48. Lambert, E., Hotchkin, E., Alvarenga, M., Pier, C., Richards, J., Barton, D., et al. (2006). Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. J. Physiol. 570, 637-643. doi: 10.1113/jphysiol.2005.100040.
49. Lampert, R., Shusterman, V., Burg, M. M., Lee, F. A., Earley, C., Goldberg, A., et al. (2005). Effects of psychologic stress on repolarization and relationship to autonomic and hemodynamic factors. J. Cardiovasc. Electrophysiol. 16, 372-377. doi: 10.1046/j.1540-8167.2005.40580.x.
50. Martin, P., Massol, J., and Puech, A. J. (1990). Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats. Biol. Psychiatry 27, 968-974. doi: 10.1016/0006-3223(90)90034-Y.
51. Martins Lima, A., Xavier, C. H., Ferreira, A. J., Raizada, M. K., Wallukat, G., Santos, R. A., et al. (2013). Activation of angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress. Am. J. Physiol. Heart. Circ. Physiol. 305, H1057-H1067. doi: 10.1152/ajpheart.00433.2013.
52. Matynia, A., Ng, C. H., Dansithong, W., Chiang, A., Silva, A. J., and Reddy, S. (2012). Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy. PLoS ONE 5:e9857. doi: 10.1371/journal.pone.0009857.
53. Mayorov, D. N., and Head, G. A. (2003). AT1 receptors in the RVLM mediate pressor responses to emotional stress in rabbits. Hypertension 41, 1168-1173. doi: 10.1161/01.HYP.0000064574.29317.45.
54. Meola, G., and Sansone, V. (2007). Cerebral involvement in myotonic dystrophies. Muscle Nerve 36, 294-306. doi: 10.1002/mus.20800.
55. Munoz, A., Rey, P., Guerra, M. J., Mendez-Alvarez, E., Soto-Otero, R., and Labandeira-Garcia, J. L. (2006). Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology 51, 112-120. doi: 10.1016/j.neuropharm.2006.03.004.
56. Ono, S., Takahashi, K., Jinnai, K., Kanda, F., Fukuoka, Y., Kurisaki, H., et al. (1998). Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology 50, 535-538. doi: 10.1212/WNL.50.2.535.
57. Penninx, B. W., Beekman, A. T., Honig, A., Deeg, D. J., Schoevers, R. A., van Eijk, J. T., et al. (2001). Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry 58, 221-227. doi: 10.1001/archpsyc.58.3.221.
58. Polakoff, R. J., Morton, A. A., Koch, K. D., and Rios, C. M. (1998). The psychosocial and cognitive impact of Duchenne's muscular dystrophy. Semin. Pediatr. Neurol. 5, 116-123. doi: 10.1016/S1071-9091(98)80027-2.
59. Politano, L., Palladino, A., Nigro, G., Scutifero, M., and Cozza, V. (2008). Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies. Acta Myol. 27, 114-122.
60. Russo, V., Rago, A., Politano, L., Papa, A. A., Di Meo, F., Russo, M. G., et al. (2012). Increased dispersion of ventricular repolarization in Emery Dreifuss muscular dystrophy patients. Med. Sci. Monit. 18, CR643-CR647. doi: 10.12659/MSM.883541.
61. Sabharwal, R., Weiss, R. M., Zimmerman, K., and Chapleau, M. W. (2010a). Angiotensin II contributes to skeletal muscle fibrosis, reduced locomotor activity and autonomic dysfunction in d-sarcoglycan deficient mice with muscular dystrophy. Hypertension (abstract) 56, E103.
62. Sabharwal, R., Weiss, R. M., and Chapleau, M. W. (2010b). Dysautonomia precedes cardiomyopathy in a mouse model of muscular dystrophy. Clin. Auton. Res. (abstract) 20, 51-52.
63. Sander, M., Chavoshan, B., Harris, S. A., Iannaccone, S. T., Stull, J. T., Thomas, G. D., et al. (2000). Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 97, 13818-13823. doi: 10.1073/pnas.250379497.
64. Schwartz, P. J., Vanoli, E., Stramba-Badiale, M., De Ferrari, G. M., Billman, G. E., and Foreman, R. D. (1988). Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78, 969-979. doi: 10.1161/01.CIR.78.4.969.
65. Sekiguchi, M., Zushida, K., Yoshida, M., Maekawa, M., Kamichi, S., Sahara, Y., et al. (2009). A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 132, 124-135. doi: 10.1093/brain/awn253.
66. Sliwa, K., Blauwet, L., Tibazarwa, K., Libhaber, E., Smedema, J. P., Becker, A., et al. (2010). Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121, 1465-1473. doi: 10.1161/CIRCULATIONAHA.109.901496.
67. Stauss, H. M. (2002). Baroreceptor reflex function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R284-R286.
68. Straub, V., Duclos, F., Venzke, D. P., Lee, J. C., Cutshall, S., Leveille, C. J., et al. (1998). Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster. Am. J. Pathol. 153, 1623-1630. doi: 10.1016/S0002-9440(10)65751-3.
69. Sun, G., Haginoya, K., Dai, H., Chiba, Y., Uematsu, M., Hino-Fukuyo, N., et al. (2009). Intramuscular renin-angiotensin system is activated in human muscular dystrophy. J. Neurol. Sci. 280, 40-48. doi: 10.1016/j.jns.2009.01.020.
70. Taylor, C. B., Youngblood, M. E., Catellier, D., Veith, R. C., Carney, R. M., Burg, M. M., et al. (2005). Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatry 62, 792-798. doi: 10.1001/archpsyc.62.7.792.
71. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163, 28-40. doi: 10.1176/appi.ajp.163.1.28.
72. Waite, A., Brown, S. C., and Blake, D. J. (2012). The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci. 35, 487-496. doi: 10.1016/j.tins.2012.04.004.
73. Walgenbach, S. C., and Shepherd, J. T. (1984). Role of arterial and cardiopulmonary mechanoreceptors in the regulation of arterial pressure during rest and exercise in conscious dogs. Mayo Clin. Proc. 59, 467-475. doi: 10.1016/S0025-6196(12)60435-2.
74. Walker, F. R. (2013). A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 67, 304-317. doi: 10.1016/j.neuropharm.2012.10.002.
75. Walther, T., Balschun, D., Voigt, J. P., Fink, H., Zuschratter, W., Birchmeier, C., et al. (1998). Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J. Biol. Chem. 273, 11867-11873. doi: 10.1074/jbc.273.19.11867.
76. Watkins, L. L., and Grossman, P. (1999). Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am. Heart J. 137, 453-457. doi: 10.1016/S0002-8703(99)70491-6.
77. Winblad, S., Jensen, C., Mansson, J. E., Samuelsson, L., and Lindberg, C. (2013). Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates. Behav. Brain Funct. 6, 25. doi: 10.1186/1744-9081-6-25.
78. Wsol, A., Cudnoch-Jedrzejewska, A., Szczepanska-Sadowska, E., Kowalewski, S., and Puchalska, L. (2008). Oxytocin in the cardiovascular responses to stress. J. Physiol. Pharmacol. 59(Suppl. 8), 123-127.
79. Xavier, C. H., Beig, M. I., Ianzer, D., Fontes, M. A., and Nalivaiko, E. (2013). Asymmetry in the control of cardiac performance by dorsomedial hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R664-R674. doi: 10.1152/ajpregu.00401.2012.
80. Young, E. A., Lopez, J. F., Murphy-Weinberg, V., Watson, S. J., and Akil, H. (2003). Mineralocorticoid receptor function in major depression. Arch. Gen. Psychiatry 60, 24-28. doi: 10.1001/archpsyc.60.1.24.